Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2. (Q40943325)

25 September 2017

title

Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2. (English)

1 reference

25 September 2017

Do-Hoon Lee

1

1 reference

25 September 2017

Na Rae Hwang

2

1 reference

25 September 2017

Myong Cheol Lim

3

1 reference

25 September 2017

Chong Woo Yoo

4

1 reference

25 September 2017

Jungnam Joo

5

1 reference

25 September 2017

Joo-Young Kim

6

1 reference

25 September 2017

Sang-Yoon Park

7

1 reference

25 September 2017

Sang-Hyun Hwang

8

1 reference

25 September 2017

publication date

20 October 2015

1 reference

Annals of Clinical Biochemistry

25 September 2017

published in

1 reference

25 September 2017

volume

53

1 reference

25 September 2017

issue

Pt 5

1 reference

25 September 2017

page(s)

561-567

1 reference

Global cancer statistics, 2012

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

A population-based evaluation of cervical screening in the United States: 2008-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Evaluation of a novel real-time RT-PCR using TOCE technology compared with culture and Seeplex RV15 for simultaneous detection of respiratory viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Detection and typing of human papillomavirus by e6 nested multiplex PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Human papillomavirus infections with multiple types and risk of cervical neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Exploring individual HPV coinfections is essential to predict HPV-vaccination impact on genotype distribution: a model-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Can clinical tests help monitor human papillomavirus vaccine impact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Comparing the performance of six human papillomavirus tests in a screening population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Comparison of Xpert MTB/RIF with ProbeTec ET DTB and COBAS TaqMan MTB for direct detection of M. tuberculosis complex in respiratory specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Development and characterization of the cobas human papillomavirus test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Principles and analytical performance of Abbott RealTime High Risk HPV test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

2012 cervical cancer screening guidelines and the future role of HPV testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215614036

21 January 2018

Identifiers

DOI

10.1177/0004563215614036

1 reference

25 September 2017

1 reference